Written question asked by Laurence Robertson (Conservative) on Thursday, 3 November 2016, in the House of Commons. It was due for an answer on Tuesday, 8 November 2016 (named day). It was answered by Baroness Blackwood of North Oxford (Conservative) on Tuesday, 8 November 2016 on behalf of the Department of Health.
NHS: Drugs
- Question
-
To ask the Secretary of State for Health, whether his Department has made an assessment of the relative cost-effectiveness of using (a) branded and (b) non branded drugs; and if he will make a statement.
- Answer
-
The National Institute for Health and Care Excellence provides guidance on the clinical and cost-effectiveness of drugs, as part of its technology appraisal programme. Non branded drugs (generics) are as effective as their branded equivalents, and usually come at much lower cost, hence are more cost-effective than branded equivalents.
Secondary information
- Type
- Written question
- Reference
- 51758
- Session
- 2016-17
- Related items
-
General Practitioners: Generic Prescribing
Thursday, 17 November 2016
Written questions
House of Commons
- Subjects
- Cost effectiveness Drugs NHS Generic prescribing
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2019-08-14 15:12:23 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/51758
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/51758
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/51758